--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Reimbursify: File Claims Fast" developer_entity: "Reimbursify" bundle_id: "com.reimbursify.Reimbursify" app_store_id: "1243424101" category: "Medical" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2026-06-24" report_date: "2026-08-02" last_verified: "2026-08-02T00:00:00.000Z" report_version: "39.0" total_reviews: 594 overall_rating: 4.2 confidence: "low" confidence_score: 0.3 data_age_days: 15 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "freemium", "mobile app", "app review", "app analysis", "patients", "seeking", "out-of-network"] canonical_url: "https://marlvel.ai/apps/reimbursify-file-claims-fast" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Reimbursify: File Claims Fast Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Freemium - **Signal**: Rating 4.22 > **TL;DR:** Reimbursify: File Claims Fast is a medical app by Reimbursify, rated 4.22/5 by 594 users, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Reimbursify: File Claims Fast is a medical app by Reimbursify. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.22/5 (594 reviews) | | **Category** | Medical | | **Developer** | Reimbursify | | **Pricing** | Freemium | | **Platforms** | iOS | | **Confidence** | Low (0.3/1.0) | | **Data Age** | 15d | ## Metadata & Market Performance - **Publisher:** Reimbursify - **Category:** Medical - **Target Audience:** Patients seeking out-of-network insurance reimbursement and practitioners managing patient billing. - **Platforms:** iOS - **Version Reviewed:** 39.0 - **Report Date:** 2026-08-02 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.3/1.0) - **App Store ID (iOS):** 1243424101 - **Bundle ID:** com.reimbursify.Reimbursify - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-08-02 ## Executive Snapshot **What it is:** Reimbursify is a medical utility app for filing out-of-network health insurance claims on iOS. **Why users hire it:** The app removes the administrative friction of manual insurance paperwork, allowing users to recover money from health plans without navigating complex carrier portals. ## App DNA (Features & Intent) - **[Differentiator] VeriFAST Benefit Verification:** Checks out-of-network coverage before appointments to estimate reimbursement potential, driving B2B adoption among practitioners. - **[Differentiator] Rejection Resolution Pathway:** Automated workflow to address and resubmit denied claims, reducing user churn by providing a recovery path. * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Claim Filing Engine:** Automated data entry and error checking, gated behind per-claim fees or annual packs to drive direct revenue. * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. ## Market Position {#market-position} Reimbursify maintains a steady utility position in the Medical category with a 4.2-star rating across 594 reviews. The lack of recent major updates suggests a stable, maintenance-focused market presence rather than aggressive growth. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free for first claim, $3.99 per single claim, $29.99 for a 10-claim pack (valid for one year) - **Analysis:** The model anchors users with a free trial claim, transitioning to transaction-based revenue for recurring users. ## SWOT Analysis {#swot} **Core Strengths:** - Patent-pending claim filing engine reduces manual error rates - Automated rejection resolution pathway provides a clear recovery path for denied claims **Growth Levers:** - Expanding provider search database improves auto-population success rates - Direct carrier API integrations could reduce claim processing time ## Recent Changes (v2 → v3) {#recent-changes} Reimbursify transitioned from a maintenance-only posture to a conversion-focused strategy, specifically targeting paywall friction and user retention. This shift is evidenced by new PM action items prioritizing value-estimation tools over stability-only development. **Overall trend**: Mixed **Compared at**: 2026-08-02 ### High-impact changes - **[Added] Expanded SWOT Analysis** (swot) - **[Shifted] Strategic Focus Shift** (positioning) ### Medium-impact changes - **[Shifted] Executive Summary Refinement** (positioning) ## What's New - **Latest (v39.0, 1 months ago):** Technical update focused on iOS 17 compatibility and general stability. ## App Momentum (Maintenance) {#momentum} - Ships stability updates at ~5-week cadence. - Last major release over six months ago. > **Cadence:** 1 total versions · 0 majors in last 6 months · 38 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Reimbursify: File Claims Fast is a medical app that is free with in-app purchases. It holds a 4.22/5 rating from 594 reviews. > **Bottom Line:** Reimbursify must pivot from its current maintenance posture to address the conversion friction caused by its per-claim pricing. Introducing value-estimation tools would unlock higher filing frequency by reducing the financial uncertainty that currently drives user churn at the paywall. **Best for:** Patients seeking out-of-network insurance reimbursement and practitioners managing patient billing. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] Audit the $3.99 per-claim price point because user reviews flag cost as a barrier for small claims → increase conversion velocity ### Outlook: Stable The out-of-network reimbursement market is consolidating around automated filing tools, and Reimbursify's current stability-focused approach risks obsolescence if competitors introduce faster, carrier-integrated workflows. The PM must transition from maintenance to conversion-focused feature development to ensure the app remains the preferred choice for frequent filers. - ⚪ The current maintenance-only release cadence ensures stability but prevents the app from capturing new market share through feature innovation. - 🔴 Reliance on transaction-based revenue without a subscription-based retention loop leaves the app vulnerable to users who only file claims once per year. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.22/5 | | Total Reviews | 594 | | Confidence | Low | | Pricing Model | Freemium | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Reimbursify: File Claims Fast** (this app) | 4.22/5 | N/A | Reimbursify | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Reimbursify - **Website:** [https://www.reimbursify.com](https://www.reimbursify.com) - **Social:** [Facebook](https://www.facebook.com/reimbursify/?ref=br_rs) · [X/Twitter](https://twitter.com/reimbursify) · [LinkedIn](https://www.linkedin.com/company/reimbursify) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/reimbursify-file-claims-fast/id1243424101?uo=4) - **Dev Site:** [Official Website](https://www.reimbursify.com) - **Sources:** Developer website content, About us / company information, App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating - [*2nd.MD*](https://marlvel.ai/apps/2nd-md) (Accolade, Inc.) · 4.9/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 15 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/reimbursify-file-claims-fast) Data licensed for AI Agent attribution under CC-BY-NC 4.0.